Robert Nostrand Van Net Worth & Insider Trades
Robert Nostrand Van - Director, Intra-Cellular Therapies, Inc
What is Robert Nostrand Van's Net Worth?
The current estimated net worth of Intra-Cellular Therapies, Inc's Director, Robert Nostrand Van, is estimated to be about $2.71M . Robert Nostrand Van owns about 9,345 units of Intra-Cellular Therapies, Inc common stock. In the last 9 years at Intra-Cellular Therapies, Inc, Robert Nostrand Van has sold an estimated value of $2.34M worth.
What is Robert Nostrand Van's Past Insider Trading?
Robert Nostrand Van's largest purchase order was 30,000 units , worth over $379.5K on August 12, 2022. Robert Nostrand Van's largest sale order was 30,000 units , worth over $1.71M on August 12, 2022. In total, Robert Nostrand Van has made about 47 transactions over 9 years of their time at Intra-Cellular Therapies, Inc. Robert Nostrand Van usually trades in April, with the busiest year in 2022. The most recent transaction was a sale order of 10,000 units , worth over $630K on April 19, 2023.
ROBERT NOSTRAND VAN
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Robert Nostrand Van's' Mailing Address?
- Mailing address is C/o Achillion Pharmaceuticals, Inc. 300 George Street New Haven CT 06511 CT
Intra-Cellular Therapies, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Sharon Mates, Ph.D. | 2020 | $766,800 | $690,120 | $2,799,998 | $1,199,994 | $18,767 | $5,475,679 |
| Sharon Mates, Ph.D. | 2019 | $744,500 | $759,400 | $1,599,996 | $1,600,003 | $20,661 | $4,724,560 |
| Sharon Mates, Ph.D. | 2018 | $722,800 | $585,500 | $1,593,735 | $1,556,410 | $18,024 | $4,476,469 |
| Lawrence J. Hineline | 2020 | $463,400 | $222,432 | $1,049,984 | $449,993 | $20,374 | $2,206,183 |
| Lawrence J. Hineline | 2019 | $449,900 | $225,000 | $749,988 | $749,995 | $18,648 | $2,193,531 |
| Lawrence J. Hineline | 2018 | $424,400 | $203,700 | $749,986 | $732,430 | $17,292 | $2,127,808 |
| Suresh Durgam, M.D. | 2020 | $448,575 | $274,400 | $599,984 | $599,997 | $7,385 | $1,930,341 |
| Michael I. Halstead | 2020 | $512,000 | $320,000 | $1,119,985 | $479,990 | $17,931 | $2,449,906 |
| Michael I. Halstead | 2019 | $497,100 | $323,100 | $749,988 | $749,995 | $17,270 | $2,337,453 |
| Michael I. Halstead | 2018 | $469,000 | $225,100 | $749,986 | $732,430 | $16,680 | $2,193,196 |
| Mark Neumann | 2020 | $518,900 | $324,312 | $1,119,985 | $479,990 | $130,085 | $2,573,272 |
| Mark Neumann | 2019 | $503,800 | $277,100 | $799,991 | $799,997 | $133,449 | $2,514,337 |
| Mark Neumann | 2018 | $106,090 | $245,500 | $749,995 | $749,990 | $25,124 | $1,876,699 |
| Andrew Satlin, M.D. | 2020 | $480,634 | $0 | $1,119,985 | $479,990 | $20,585 | $2,101,194 |
| Andrew Satlin, M.D. | 2019 | $515,000 | $360,500 | $874,997 | $874,996 | $19,332 | $2,644,825 |
| Andrew Satlin, M.D. | 2018 | $500,000 | $300,000 | $0 | $0 | $11,792 | $811,792 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm
What are Intra-Cellular Therapies, Inc's Past Insider Trades?
Intra-Cellular Therapies, Inc's most recent insider trade came on April 19, 2023 by Robert Nostrand Van who sold 10,000 units worth $630K . In the last 9 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $123.34M and bought an estimated value of $64.62M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director, Rory Riggs, Director, and Robert Nostrand Van, Director .
Intra-Cellular Therapies, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||